ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31

ACCENDRA HEALTH INC/VA/

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$0.22−0.01 (-6.30%)

Close on Oct 19, 2026

Market cap: $16.89M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt

$1.72B

$0 due within a year

Net debt

$1.71B

After $7.65M of cash

Implied interest rate

5.51%

FY2025 interest ÷ average debt

Interest coverage

0.3×

FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Accendra Health's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Accendra Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-2 split on Apr 1, 2010
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACH.

Revenue growth-3.3% · median 6.1%

Gross margin44.8% · median 18.9%

Operating margin1.1% · median 3.9%

Net margin-11.4% · median 3.0%

Company	Revenue	Growth
HSIC	$13.60B	+6.5%
AHCO	$3.23B	+4.2%
SCSC	$3.23B	+6.1%
CNXN	$2.99B	+3.2%
ACH	$2.65B	-3.3%
PLUS	$2.45B	+16.5%

Company

Next earnings (est.): Oct 29, 2026, after close
Exchange: NYSE
Industry: Wholesale-Medical, Dental & Hospital Equipment & Supplies
Fiscal year ends: December 31
Employees: 6,500
Held by institutions: 81.1%
Auditor: KPMG, LLP
SEC CIK: 75252

Advertisement
300 × 250